The Wren Laboratories NETest and its recent expansion into the Chinese Market was the subject of a feature article by Forest Ray in GenomeWeb.com. The article characterized our decision to focus on mRNA as the basis for our diagnostic platform and also discusses a little bit about diagnostics in our pipeline, specifically our PROSTest.
Read the article: https://www.genomeweb.com/cancer/wren-labs-launches-neuroendocrine-tumor-liquid-biopsy-asia-works-expanding-testing-menu
Recent Comments